Arcoma

Arcoma Accounts Payable

The Accounts Payable of Arcoma (ARCOMA.ST) as of Nov 2, 2026 is 15.53 M SEK. In the previous year, Accounts Payable was 14.21 M SEK — a change of 9.24% (higher).

Accounts Payable

15.53 MSEK

YoY

9.24%

Last updated:

Accounts Payable of Arcoma is 2025 15.53 M SEK. Accounts Payable of Arcoma was 2024 14.21 M SEK. It decreases by 9.24% higher compared to the previous year.

The Arcoma Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
17.08 M SEK
Jan 1, 2019
18.00 M SEK
Jan 1, 2020
18.36 M SEK
Jan 1, 2021
12.24 M SEK
Jan 1, 2022
23.14 M SEK
Jan 1, 2023
21.44 M SEK
Jan 1, 2024
14.21 M SEK
Jan 1, 2025
15.53 M SEK
The Arcoma Accounts Payable history
YEARAccounts PayableYoY
15.53 MSEK+9.24%
14.21 MSEK-33.70%
21.44 MSEK-7.36%
23.14 MSEK+89.01%
12.24 MSEK-33.31%
18.36 MSEK+2.01%
18.00 MSEK+5.36%
17.08 MSEK+51.34%
11.29 MSEK+6.89%
10.56 MSEK-22.24%
13.58 MSEK-3.76%
14.11 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Accounts Payable of Arcoma is 15.53 M SEK in 2025.

Accounts Payable of Arcoma changed from 14.21 M SEK to 15.53 M SEK, representing a 9.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Arcoma since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Arcoma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Arcoma

All Key Metrics — Arcoma